Latest Finance News

AVADA Group reported a 14.9% rise in cash receipts for Q1 2026, underpinned by strong sales in Queensland and New South Wales, while completing a refinancing that improves liquidity and covenant headroom.

Chalice Mining has bolstered its leadership and financing strategy while advancing a Feasibility Study for its Gonneville palladium-nickel-copper project, amid improving market conditions and promising exploration results.

MPR Australia has no ongoing operations following its $19 million asset sale and is weighing shareholder returns against new business acquisitions amid legacy claims.

Celsius Resources appoints Bardin Davis as MD to lead financing efforts for the MCB Copper-Gold Project, extends Final Investment Decision timeline to late 2026, and navigates a complex ownership dispute in the Philippines while raising A$9.3 million.

QPM Energy has secured critical approvals and financing milestones for its 112MW Isaac Power Station, alongside a significant upgrade to its Moranbah Gas Project reserves, positioning it as a key energy supplier in Queensland.

Genesis Resources progresses environmental work at its Plavica project in North Macedonia while Australian field activities stall due to wet season, reporting a A$401k operating cash outflow and under two quarters of funding.

Focus Minerals Ltd maintained steady gold production and processing efficiency at Coolgardie during the March 2026 quarter, generating robust sales revenue and a healthy cash position.

Brockman Mining Limited continues to develop its Marillana and Ophthalmia iron ore projects through joint ventures, progressing infrastructure plans at Port Hedland while maintaining a modest cash position and strong financing facilities.

Lindian Resources has begun full-scale construction at its Kangankunde Rare Earths Project and secured the SARECO Mixed Rare Earth Carbonate facility in Kazakhstan, positioning itself as a rare earths producer with downstream processing capabilities.

Altech Batteries has won conditional approval for a €46.11 million German government grant supporting its CERENERGY® Sodium-Chloride Solid-State battery project, while shifting its Silumina AnodesTM R&D operations to Germany to enhance efficiency and cut costs.

Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.

Green Technology Metals (ASX: GT1) sharpens focus on its Seymour Lithium Project amid a lithium price rebound, key permitting progress, and extended C$100 million financing interest from Export Development Canada.